Selected article for: "live virus and lung tracheal"
Author: Qu, Di; Zheng, Bojian; Yao, Xin; Guan, Yi; Yuan, Zheng-Hong; Zhong, Nan-Shan; Lu, Li-Wei; Xie, Jian-Ping; Wen, Yu-Mei
Title: Intranasal immunization with inactivated SARS-CoV (SARS-associated coronavirus) induced local and serum antibodies in mice
  • Cord-id: i8zkdx7u
  • Document date: 2005_1_4
    • ID: i8zkdx7u
    Snippet: SARS-CoV (severe acute respiratory syndrome-associated coronavirus) strain GZ50 was partially purified and inactivated with 1:2000 formaldehyde. In cell culture the inactivated virus blocked the replication of live virus by decreasing the TCID(5.0) of the live virus 10(3.6) to 10(4.6) times. Inactivated GZ50 was used to immunize mice intranasally either alone, or after precipitation with polyethylene glycol (PEG), or with CpG, or CTB as an adjuvant. The titer of serum neutralizing antibodies was
    Document: SARS-CoV (severe acute respiratory syndrome-associated coronavirus) strain GZ50 was partially purified and inactivated with 1:2000 formaldehyde. In cell culture the inactivated virus blocked the replication of live virus by decreasing the TCID(5.0) of the live virus 10(3.6) to 10(4.6) times. Inactivated GZ50 was used to immunize mice intranasally either alone, or after precipitation with polyethylene glycol (PEG), or with CpG, or CTB as an adjuvant. The titer of serum neutralizing antibodies was up to 1:640. In mice immunized with adjuvants or PEG precipitated GZ50, specific IgA was detected in tracheal-lung wash fluid by immunofluorescence. Though serum antibodies were detected, no anti-SARS-IgA could be detected in mice immunized only with inactivated GZ50. The roles of adjuvants in intranasal immunization with inactivated. SARS-CoV is discussed.

    Search related documents:
    Co phrase search for related documents
    • accession number and adenovirus spike protein: 1
    • acute respiratory syndrome and adenovirus spike protein: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • acute respiratory syndrome and adjuvant alum: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • acute respiratory syndrome and adjuvant alum immunization: 1
    • acute respiratory syndrome and adjuvant inactivated virus: 1
    • acute respiratory syndrome and adjuvant plus virus: 1
    • acute respiratory syndrome and adjuvant provide: 1, 2, 3
    • acute respiratory syndrome and administration site: 1
    • acute respiratory syndrome and live sars cov replication: 1, 2